This guidance has been approved for use in Scotland by the Scottish Health Protection Network Guidance Group (SHPN-GG). The guidance should be used in conjunction with the SHPN addendum.
The PHE guidance on use of antiviral agents for the treatment and prophylaxis of influenza covers:
- treatment of suspected or confirmed influenz
- post-exposure prophylaxis supply of zanamivir acqueous solution
- use of anti-virals in pregnancy, breastfeeding, hepatic or renal dysfunction